State Street’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

State Street’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-476,648	Closed	-$17.1M	–	4916
2022 Q4	$17.1M	Buy	476,648 +82,009	+21%	+$2.05M	﹤0.01%	2355
2022 Q3	$5.94M	Buy	394,639 +45,907	+13%	+$745K	﹤0.01%	2977
2022 Q2	$4.67M	Buy	348,732 +89,901	+35%	+$1.43M	﹤0.01%	3135
2022 Q1	$4.99M	Buy	258,831 +108,040	+72%	+$2.24M	﹤0.01%	3180
2021 Q4	$3.58M	Buy	150,791 +41,171	+38%	+$954K	﹤0.01%	3403
2021 Q3	$2.2M	Buy	+109,620	New	+$2.35M	﹤0.01%	3583

State Street's IMGO Position: Q1 2023 in Review

State Street sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 476,648 shares — an estimated $17.1M sold.

State Street first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $17.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

State Street reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
State Street sold 476,648 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $17.1M.
State Street first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
State Street's Imago BioSciences, Inc. Common stock position peaked at $17.1M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.